TY  - GEN
AU  - Kloke,O
AU  - Klaassen,U
AU  - Oberhoff,C
AU  - Hartwich,G
AU  - Szanto,J
AU  - Wolf,E
AU  - Heckmann,M
AU  - Huhn,R
AU  - Stephan,L
AU  - Schnepper,U
AU  - Donsbach,G M
AU  - Bechtel,C
AU  - Rudolph,R
AU  - Berke,A
AU  - Borquez,D
AU  - Hawig,I
AU  - Hirche,H
AU  - Schindler,A E
AU  - Seeber,S
AU  - Becher,R
TI  - Maintenance treatment with medroxyprogesterone acetate in patients with advanced breast cancer responding to chemotherapy: results of a randomized trial. Essen Breast Cancer Study Group
SN  - 0167-6806
PY  - 1999///1025
KW  - Aged
KW  - Antineoplastic Agents, Hormonal
KW  - therapeutic use
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Disease-Free Survival
KW  - Epirubicin
KW  - administration & dosage
KW  - Female
KW  - Germany
KW  - Humans
KW  - Ifosfamide
KW  - Medroxyprogesterone Acetate
KW  - Middle Aged
KW  - Prospective Studies
KW  - Quality of Life
KW  - Survival Analysis
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1023/a:1006169012544
ER  -